Kahn Brothers Group Inc's PFE Position
Pfizer — 10 quarters (Q4 2023 to Q4 2025)
Current Shares
554.0K
Current Value
$13.79M
Peak Shares
1.03M
Q4 2023
Overall Change
-46%
Shares Over Time
Q4 2023
1.03M
Q1 2024
1.02M
0%
Q2 2024
1.00M
-2%
Q3 2024
997.0K
-1%
Q4 2024
761.1K
-24%
Q1 2025
735.2K
-3%
Q2 2025
731.0K
-1%
Q3 2025
707.1K
-3%
Q3 2025
707.1K
0%
Q4 2025
554.0K
-22%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change |
|---|---|---|---|---|
| Q4 2025 | 554.0K | $13.79M | $24.90 | -22% |
| Q3 2025 | 707.1K | $18.02M | $25.48 | 0% |
| Q3 2025 | 707.1K | $18.02M | $25.48 | -3% |
| Q2 2025 | 731.0K | $17.72B | $24240.00 | -1% |
| Q1 2025 | 735.2K | $18.63M | $25.34 | -3% |
| Q4 2024 | 761.1K | $20.19B | $26530.37 | -24% |
| Q3 2024 | 997.0K | $28.85B | $28939.88 | -1% |
| Q2 2024 | 1.00M | $28.05B | $27979.80 | -2% |
| Q1 2024 | 1.02M | $28.38B | $27749.76 | 0% |
| Q4 2023 | 1.03M | $29.53B | $28790.26 | New |